13F HOLDINGS REPORT
Saturn V Capital Management LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001964437-23-000004
Total Value
$180.3M
Positions
20
Other Managers
0
Confidential Omitted
No
Holdings (20)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CHINOOK THERAPEUTICS INC | 16961L106 | 524,811 | $20.2M | 11.18% |
| 2 | CRINETICS PHARMACEUTICALS IN | CRNX | 938,677 | $16.9M | 9.38% |
| 3 | COGENT BIOSCIENCES INC | COGT | 1,143,368 | $13.5M | 7.51% |
| 4 | CYTOKINETICS INC | CYTK | 406,225 | $13.3M | 7.35% |
| 5 | CYMABAY THERAPEUTICS INC | 23257D103 | 1,187,801 | $13.0M | 7.21% |
| 6 | KALVISTA PHARMACEUTICALS INC | KALV | 1,412,336 | $12.7M | 7.05% |
| 7 | BIOGEN INC | BIIB | 41,047 | $11.7M | 6.48% |
| 8 | HORIZON THERAPEUTICS PUB L | G46188101 | 99,495 | $10.2M | 5.68% |
| 9 | APELLIS PHARMACEUTICALS INC | APLS | 107,406 | $9.8M | 5.43% |
| 10 | MORPHIC HLDG INC | 61775R105 | 152,360 | $8.7M | 4.84% |
| 11 | ITEOS THERAPEUTICS INC | 46565G104 | 636,158 | $8.4M | 4.67% |
| 12 | BIOMARIN PHARMACEUTICAL INC | BMRN | 92,626 | $8.0M | 4.45% |
| 13 | ASCENDIS PHARMA A/S | ASND | 78,442 | $7.0M | 3.88% |
| 14 | BIOCRYST PHARMACEUTICALS INC | BCRX | 954,856 | $6.7M | 3.73% |
| 15 | SAREPTA THERAPEUTICS INC | SRPT | 53,995 | $6.2M | 3.43% |
| 16 | ASTRIA THERAPEUTICS INC | 04635X102 | 637,857 | $5.3M | 2.95% |
| 17 | SYNDAX PHARMACEUTICALS INC | SNDX | 173,717 | $3.6M | 2.02% |
| 18 | SAGE THERAPEUTICS INC | 78667J108 | 70,559 | $3.3M | 1.84% |
| 19 | ARGENX SE | ARGX | 4,081 | $1.6M | 0.88% |
| 20 | SCILEX HOLDING CO | SCLXW | 10,390 | $57,872 | 0.03% |